Author:
Slovak Marilyn L.,Bedell Victoria,Lew Danika,Albain Kathy S.,Ellis Georgiana K.,Livingston Robert B.,Martino Silvana,Perez Edith A.,Hortobagyi Gabriel N.,Sher Dorie,Stock Wendy
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Vardiman JW, Arber DA, Brunning RD et al (2008) Therapy-related myeloid neoplasm. In: Swerdlow SH, Campo E, Harris NL et al (eds) World Health Organization classification of tumours of haematopoietic and lymphoid tissue. IARC, Lyon
2. Crump M, Tu D, Shepherd L, Levine M, Bramwell V, Pritchard K (2003) Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1(16):3066–3071. doi: 10.1200/JCO.2003.08.137
3. Hershman D, Neugut AI, Jacobson JS et al (2007) Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst 99(3):196–205. doi: 10.1093/jnci/djk028
4. Le Deley MC, Suzan F, Cutuli B et al (2007) Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. J Clin Oncol 25(3):292–300. doi: 10.1200/JCO.2006.05.9048
5. Leone G, Pagano L, Ben-Yehuda D, Voso MT (2007) Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica 92(10):1389–1398. doi: 10.3324/haematol.11034
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献